# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-038633
Filing Date
2025-04-24
Accepted
2025-04-24 16:42:07
Documents
20
Period of Report
2025-06-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | tm252466-5_def14a.htm iXBRL | DEF 14A | 536353
6 | GRAPHIC | lg_markertherapeutics-4clr.jpg | GRAPHIC | 31700
7 | GRAPHIC | bc_comptsr-4c.jpg | GRAPHIC | 64305
8 | GRAPHIC | bc_netincome-4c.jpg | GRAPHIC | 60911
9 | GRAPHIC | px_25markertheproxy1pg01-4c.jpg | GRAPHIC | 284878
10 | GRAPHIC | px_25markertheproxy1pg02-bw.jpg | GRAPHIC | 287283
| Complete submission text file | 0001104659-25-038633.txt |  | 2941779

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | mrkr-20241231.xsd | EX-101.SCH | 10144
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | mrkr-20241231_def.xml | EX-101.DEF | 3704
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | mrkr-20241231_lab.xml | EX-101.LAB | 35672
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | mrkr-20241231_pre.xml | EX-101.PRE | 6094
22 | EXTRACTED XBRL INSTANCE DOCUMENT | tm252466-5_def14a_htm.xml | XML | 88290

Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37939 | Film No.: 25868234
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)